A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome
information for practice,
Hypomethylating agents (HMA), azacitidine, and decitabine are frequently used in the management of myelodysplastic syndromes (MDS…